Tandem Diabetes Care Announces Third Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

Go back to Tandem Diabetes Care Announces Third Quarter 2021 Financial Results and Updated Full Year 2021 Sales Guidance

Tandem Diabetes (TNDM) Tops Q3 EPS by 3c

November 3, 2021 4:54 PM EDT

Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of $0.09, $0.03 better than the analyst estimate of $0.06. Revenue for the quarter came in at $179.6 million versus the consensus estimate of $171.37 million.

GUIDANCE:

Tandem Diabetes sees FY2021 revenue of $685-695 million, versus the consensus... More